The Current Ratio as of December 2025 (TTM) for Concert Pharmaceuticals, Inc. (CNCE) is 9.33

According to Concert Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 9.33. This represents a change of 3.61% compared to the average of 9.00 of the last 4 quarters.

Concert Pharmaceuticals, Inc. (CNCE) Historical Current Ratio (quarterly & annually)

How has CNCE Current Ratio performed in the past?

The mean historical Current Ratio of Concert Pharmaceuticals, Inc. over the last ten years is 13.21. The current 9.33 Current Ratio has changed 6.96% with respect to the historical average. Over the past ten years (40 quarters), CNCE's Current Ratio was at its highest in in the June 2018 quarter at 33.89. The Current Ratio was at its lowest in in the March 2013 quarter at 0.

Concert Pharmaceuticals, Inc. (CNCE) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Concert Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Concert Pharmaceuticals, Inc. (CNCE) Average Current Ratio

How has CNCE Current Ratio performed in the past?

The current Current Ratio of Concert Pharmaceuticals, Inc. (CNCE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Concert Pharmaceuticals, Inc. (CNCE) Current Ratio vs. Peers

How is CNCE’s Current Ratio compared to its peers?

Concert Pharmaceuticals, Inc.’s Current Ratio is greater than Orchard Therapeutics plc (2.78), greater than Revance Therapeutics, Inc. (4.12), greater than Vigil Neuroscience, Inc. (2.06), greater than Checkpoint Therapeutics, Inc. (1.91), greater than iTeos Therapeutics, Inc. (7.53), less than Climb Bio, Inc. (14.08), greater than G1 Therapeutics, Inc. (3.87), greater than Y-mAbs Therapeutics, Inc. (4.00), less than SomaLogic, Inc. (13.42), greater than scPharmaceuticals Inc. (3.85),

Build a custom stock screener for Concert Pharmaceuticals, Inc. (CNCE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Concert Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Concert Pharmaceuticals, Inc. (CNCE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Concert Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.